Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Breast Cancer treatment details. Chemotherapy. Medical Center Alkmaar, Alkmaar, Netherlands



Survival: 16.8 months
   
Toxicity Grade: 5
   
Treatments: Chemotherapy
   
Drugs:
Country: Netherlands
   
City/State/Province: Alkmaar
   
Hospital: Medical Center Alkmaar
   
Journal: Link
   
Date: 3/2014

Description:
Patients:
This phase 3 study involved elderly (65 years or older) female metastatic breast cancer patients who were divided into two different treatment groups. Group A consisted of 40 patients, while group B had 38 patients.

Treatment:
Patients in group A were treated with the chemotherapy agent pegylated liposomal doxorubicin (PLD).

Patients in group B received chemotherapy with capecitabine.

Toxicities:
The most severe toxicities in group A were of grade 3 and included fatigue, hand-foot syndrome (skin toxicity), and stomatitis (inflammation of the stomach lining).

There was one treatment-related death due to gastrointestinal bleeding in group B. Grade 3 fatigue, hand-foot syndrome (skin toxicity), and diarrhea were also reported.

Results:
The median overall survival rates in group A and B were 13.8 and 16.8 months, respectively.

Support:
This study was supported by the following pharmaceutical companies: Amgen, Schering Plough, and Janssen Cilag.

Correspondence: Dr. C. H. Smorenburg; email: c.smorenburg@nki.nl

E-mail to a Friend Email Physician More Information